Shanghai Yizhong Pharmaceutical Co (SHSE:688091) Construction In Progress: ¥161.7 Mil (As of Mar. 2026)


SHSE:688091 Shanghai Yizhong Pharmaceutical Co Ltd SHSE:688091
58 GF Score
Price ¥44.43
GF Value ¥49.46
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Shanghai Yizhong Pharmaceutical Co Construction In Progress?

Shanghai Yizhong Pharmaceutical Co SHSE:688091 +0.61% 58 Construction In Progress is ¥161.7 Mil as of Mar. 2026. GuruFocus rates SHSE:688091 with a GF Score™ of 58/100 and a GF Value™ of ¥49.46 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Shanghai Yizhong Pharmaceutical Co's quarterly construction in progress increased from Sep. 2025 (¥143.4 Mil) to Dec. 2025 (¥156.5 Mil) and increased from Dec. 2025 (¥156.5 Mil) to Mar. 2026 (¥161.7 Mil).

Shanghai Yizhong Pharmaceutical Co's annual construction in progress increased from Dec. 2023 (¥4.8 Mil) to Dec. 2024 (¥39.5 Mil) and increased from Dec. 2024 (¥39.5 Mil) to Dec. 2025 (¥156.5 Mil).

Shanghai Yizhong Pharmaceutical Co Construction In Progress Historical Data

* Premium members only.

The historical data trend for Shanghai Yizhong Pharmaceutical Co's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Yizhong Pharmaceutical Co Construction In Progress Chart

Shanghai Yizhong Pharmaceutical Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Construction In Progress
Get a 7-Day Free Trial Premium Member Only 1.58 39.44 4.81 39.49 156.51

Shanghai Yizhong Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 59.79 83.82 143.38 156.51 161.66
SHSE:688091
58GF Score
Shanghai Yizhong Pharmaceutical Co Ltd SHSE:688091
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai Yizhong Pharmaceutical Co Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of ¥161.7 Mil mean?
Shanghai Yizhong Pharmaceutical Co (SHSE:688091) has a Construction In Progress of ¥161.7 Mil as of Mar. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on Shanghai Yizhong Pharmaceutical Co and its competitors.
Is Shanghai Yizhong Pharmaceutical Co's Construction In Progress too high?
Shanghai Yizhong Pharmaceutical Co's current Construction In Progress is ¥161.7 Mil. Overall, Shanghai Yizhong Pharmaceutical Co has a GF Score™ of 58/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Yizhong Pharmaceutical Co's Construction In Progress compare to ZTS and UTHR?
Shanghai Yizhong Pharmaceutical Co's Construction In Progress of ¥161.7 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Drug Manufacturers company?
A good Construction In Progress depends on the Drug Manufacturers industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Shanghai Yizhong Pharmaceutical Co and its competitors. Shanghai Yizhong Pharmaceutical Co's current Construction In Progress is ¥161.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Yizhong Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Yizhong Pharmaceutical Co (SHSE:688091) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥49.46, compared to a current price of ¥44.43 — trading 10.2% below its estimated fair value. The current Construction In Progress is ¥161.7 Mil. Shanghai Yizhong Pharmaceutical Co's overall GF Score™ is 58/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Shanghai Yizhong Pharmaceutical Co (SHSE:688091), the current Construction In Progress is ¥161.7 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai Yizhong Pharmaceutical Co (SHSE:688091) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Yizhong Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥44.43 is trading 10.2% below its estimated GF Value™ of ¥49.46. GuruFocus considers Shanghai Yizhong Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for SHSE:688091:

  • Construction In Progress: ¥161.7 Mil
  • GF Value™: ¥49.46 vs. price of ¥44.43 (10.2% below fair value)
  • GF Score™: 58/100 with 3 warning signs

No single metric tells the full story. See the SHSE:688091 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shanghai Yizhong Pharmaceutical Co Business Description

Address 79 Renqi Road, Fengxian District, Shanghai, CHN, 201403
Shanghai Yizhong Pharmaceutical Co Ltd is a pharmaceutical enterprise integrating research and development, production and sales. It is committed towards the development of new dosage forms of anti-tumor drugs and related products.
58GF Score

Get the complete analysis for SHSE:688091

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥44.43
Price
¥49.46
GF Value